GlassScriptPhysician profile
Douglas Elenz
NPI 1205806171
$128,665.24
in general payments reported to CMS, 2019-2025
24 companies · $33K in 2025
The $33K reported for 2025 was more than what 93% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $3,593 · 2021: $165 · 2022: $26K · 2023: $31K · 2024: $35K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $99K · Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $98,584.13 |
| Food and Beverage | $294.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $127,030.01 | 2019-2025 | A.L.P.S. |
| Medinc of Texas | $610.00 | 2020 | |
| Stryker Corporation | $210.88 | 2019-2024 | Infinity Adaptis, Inbone, Iconix |
| Depuy Synthes Sales INC. | $108.13 | 2019-2022 | |
| Smith+Nephew, INC. | $89.10 | 2020-2024 | Spatial Frame, Bone Anchors With Arthroscopic Delivery System, Pico 7 |
| Si-Bone, INC. | $72.62 | 2021-2022 | |
| Abbott Laboratories | $68.21 | 2023-2025 | Proclaim, Protg |
| Bioventus LLC | $65.32 | 2021-2022 | |
| Radius Health, INC. | $49.73 | 2021-2022 | |
| Vericel Corporation | $45.45 | 2020-2024 | Maci |
| Pacira Pharmaceuticals Incorporated | $37.81 | 2019-2024 | Exparel, Zilretta, Iovera |
| Ermi LLC | $35.23 | 2024 | |
| Osteocentric Technologies, INC. | $33.36 | 2020 | |
| Anika Therapeutics, INC. | $29.23 | 2023 | Tactoset |
| Innovation Technologies INC | $28.45 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $20.88 | 2021 | |
| Orthogenrx INC. | $20.75 | 2019 | |
| Fidia Pharma USA INC. | $20.10 | 2019 | |
| Wright Medical Technology, INC. | $20.02 | 2020 | |
| Sanofi-Aventis U.S. LLC | $17.84 | 2019 | |
| Orthofix Medical, INC. | $15.96 | 2019-2020 | |
| Nevro Corp. | $13.75 | 2022 | |
| Pacira Therapeutics, INC. | $11.39 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,293,453.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Elenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.